Randomized Phase 2 Trial And Open-Label Extension Of Domagrozumab In Duchenne Muscular Dystrophy (Vol 30, Pg 492, 2020)
Kathryn R. Wagner,Hoda Z. Abdel-Hamid,Jean K. Mah,Craig Campbell,Michela Guglieri,Francesco Muntoni,Yasuhiro Takeshima,Craig M. Mcdonald,Anna Kostera-Pruszczyk,Peter Karachunski,Russell J. Butterfield,Eugenio Mercuri,Chiara Fiorillo,Enrico S. Bertini,Cuixia Tian,Jeffery Stanland,Alesia B. Sadosky,Vivek S. Purohit,Sarah P. Sherlock,Jeffrey P. Palmer,Michael Binks,Lawrence Charnas,Shannon Marraffino,Brenda L. Wong NEUROMUSCULAR DISORDERS(2021)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper